Judelson David

Avg. Two Year Performance

(6%) Avg. Purchase Return
(3%) Compound
No sale track record
1 Mo3 Mo6 Mo1 Yr2 Yr
Average Purchase Return(6%)(31%)(34%)(62%)(6%)
Purchase Success Rate0 of 20 of 20 of 20 of 20 of 2
Average Sale Return----------
Sale Success Rate----------

Biopure Corp.

Drugs » Biotechnology

Director:

Holdings: 376.02K shares

Sentiment

Insider Trading Sentiment: Hold

Avg. Two Year Performance

No purchase track record
No sale track record

Last Three Months:

0 Net Amount
Buy:0--
Sell:0--